Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CoreWeave
CRWV
5
Palantir
PLTR
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 9.51%48.3B | 14.08%33.66B | 19.37%22.53B | 20.01%10.15B | 23.70%44.11B | 21.70%29.51B | 24.07%18.87B | 24.39%8.46B | 22.11%35.66B | 21.95%24.25B |
Operating income | 9.51%48.3B | 14.08%33.66B | 19.37%22.53B | 20.01%10.15B | 23.70%44.11B | 21.70%29.51B | 24.07%18.87B | 24.39%8.46B | 22.11%35.66B | 21.95%24.25B |
Operating expenses | -12.65%-27.86B | -16.36%-8.48B | -18.02%-24.73B | -20.22%-7.29B | -26.43%-20.95B | |||||
Gross profit | 21.46%5.8B | 42.80%1.66B | 45.12%4.78B | 58.86%1.17B | -0.51%3.29B | |||||
Selling expenses | ---- | 29.97%-2.71M | ---- | 11.36%-782.17K | ---- | 83.15%-3.87M | ---- | 85.61%-882.44K | ---- | -57.29%-22.97M |
Administrative expenses | ---- | -14.71%-701M | ---- | -1.67%-205.95M | ---- | -15.47%-611.12M | ---- | -31.66%-202.56M | ---- | -15.01%-529.22M |
Research and development expenses | ---- | -12.97%-913.98M | ---- | -41.72%-334.36M | ---- | -28.57%-809.01M | ---- | -23.73%-235.93M | ---- | 3.02%-629.25M |
Profit from asset sales | ---- | -94.74%25.22K | ---- | 427.47%1.12M | ---- | -17.10%479.05K | ---- | 593.99%212.69K | ---- | 120.70%577.86K |
Employee expense | -2.32%-8.39B | ---- | -16.53%-3.9B | ---- | -10.63%-8.2B | ---- | -15.73%-3.35B | ---- | -22.95%-7.41B | ---- |
Depreciation and amortization | -12.90%-6.33B | ---- | -15.58%-3.04B | ---- | -11.04%-5.61B | ---- | -6.79%-2.63B | ---- | -3.82%-5.05B | ---- |
Revaluation surplus | ---- | -31.95%42.58M | ---- | -2.62%32.36M | ---- | 9.41%62.58M | ---- | -14.50%33.23M | ---- | -3.42%57.19M |
-Changes in the fair value of other assets | ---- | -31.95%42.58M | ---- | -2.62%32.36M | ---- | 9.41%62.58M | ---- | -14.50%33.23M | ---- | -3.42%57.19M |
Impairment and provision | 110.76%6.09M | 185.39%19.22M | 124.41%4.56M | 102.00%189.94K | 28.95%-56.58M | -7.22%-22.5M | -27.71%-18.67M | 10.00%-9.48M | 96.07%-79.63M | 2.19%-20.99M |
-Impairment of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 98.50%-30.2M | ---- |
-Other impairment is provision | 110.76%6.09M | 185.39%19.22M | 124.41%4.56M | 102.00%189.94K | -14.45%-56.58M | -7.22%-22.5M | -27.71%-18.67M | 10.00%-9.48M | -213.71%-49.44M | 2.19%-20.99M |
Special items of operating profit | -12.37%-28.45B | 8.17%328.93M | -18.25%-12.87B | -34.90%76.17M | -24.47%-25.32B | -32.56%304.09M | -27.16%-10.89B | -49.82%117.01M | -38.34%-20.34B | 14.14%450.9M |
Operating profit | 3.96%5.05B | 23.52%4.53B | 36.56%2.69B | 42.14%1.22B | 78.28%4.86B | 42.34%3.66B | 55.46%1.97B | 34.76%861.1M | 76.69%2.72B | -0.83%2.57B |
Financing income | -34.63%118.42M | ---- | -22.27%59.55M | ---- | 46.75%181.13M | ---- | 64.15%76.6M | ---- | -0.40%123.43M | ---- |
Financing cost | 21.23%-785.14M | -57.38%-764.19M | 7.60%-449.92M | -10.48%-222.86M | -28.27%-996.8M | -851.63%-485.56M | -28.28%-486.91M | 0.25%-201.72M | 6.51%-777.11M | 111.00%64.6M |
Share of profits of associates | 22.64%218.69M | ---- | 29.56%95.8M | ---- | -37.99%178.31M | ---- | -56.89%73.95M | ---- | -22.91%287.56M | ---- |
Special items of earning before tax | 171.20%67.76M | ---- | -94.90%11.59M | ---- | -96.00%24.99M | ---- | -30.83%227.51M | ---- | 631.40%624.21M | ---- |
Adjustment items of earning before tax | ---- | -288.88%-115.2M | ---- | -162.61%-61.06M | ---- | -2,675.13%-29.62M | ---- | -575.24%-23.25M | ---- | 121.77%1.15M |
Earning before tax | 10.00%4.67B | 15.81%3.65B | 29.34%2.41B | 47.78%940.09M | 42.31%4.24B | 19.28%3.15B | 29.74%1.86B | 44.03%636.13M | 173.64%2.98B | 31.80%2.64B |
Tax | -32.07%-1.27B | -46.55%-1.01B | -72.09%-699.4M | -38.76%-249.45M | -99.11%-960.24M | -32.02%-689.31M | -25.38%-406.41M | -32.63%-179.76M | 37.16%-482.28M | 3.34%-522.14M |
After-tax profit from continuing operations | 3.55%3.4B | 7.19%2.64B | 17.41%1.71B | 51.33%690.64M | 31.35%3.28B | 16.14%2.46B | 31.01%1.46B | 49.07%456.37M | 676.03%2.5B | 44.77%2.12B |
After-tax profit from non-continuing business | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 |
Earning after tax | 3.55%3.4B | 7.19%2.64B | 17.41%1.71B | 51.33%690.64M | 31.35%3.28B | 16.14%2.46B | 31.01%1.46B | 49.07%456.37M | 676.03%2.5B | 44.77%2.12B |
Minority profit | -2.70%262.11M | 2.98%191.78M | 0.20%117.26M | 5.44%55.13M | 91.72%269.37M | 272.20%186.22M | 1,897.01%117.03M | 2,164.43%52.28M | 1,483.36%140.51M | 387.50%50.03M |
Profit attributable to shareholders | 4.11%3.14B | 7.54%2.44B | 18.92%1.59B | 57.27%635.51M | 27.75%3.01B | 9.94%2.27B | 21.12%1.34B | 33.00%404.09M | 653.15%2.36B | 42.35%2.07B |
Basic earnings per share | 4.10%0.6574 | 6.25%0.51 | 18.92%0.3337 | 57.26%0.1332 | 27.76%0.6315 | 11.63%0.48 | 21.10%0.2806 | 32.97%0.0847 | 653.51%0.4943 | 43.33%0.43 |
Diluted earnings per share | 4.10%0.6574 | 27.76%0.6315 | 653.51%0.4943 | |||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) |
Audit Opinions | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | -- | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.